Kyocera Group

Kyocera CorporationKyocera Corporation (TYO:6971) (NYSE:KYO) the parent and global headquarters of the Kyocera Group, was founded in 1959 as a producer of fine ceramics (also known as "advanced ceramics"). By combining these engineered materials with metals and integrating them with other technologies, Kyocera has become a leading supplier of medical and dental products, industrial and automotive components, semiconductor packages, electronic devices, smart energy systems, printers, copiers, and mobile phones. During the year ended March 31, 2020, the company's consolidated sales revenue totaled 1.6 trillion yen (approx. US$14.7 billion). Kyocera is ranked #549 on Forbes magazine's 2020 "Global 2000" list of the world's largest publicly traded companies.

 
 
      

View in Other Languages

News

Regeneus Ltd (ASX:RGS) Receives Milestone Payment from Kyocera

🕔8/28/2020 10:06:35 AM 4724

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce that is has received a payment of 100M JPY (~A$1.3M) from Kyocera Corporation (Kyocera, TYO:6971)

Read Full Article

Regeneus Ltd (ASX:RGS) and Kyocera Sign Progenza OA Deal

🕔8/11/2020 9:51:25 AM 3616

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that Kyocera Corporation (Kyocera, TYO:6971) has signed a licence agreement to develop and commercialise Progenza for Knee Osteoarthritis (Progenza OA) in Japan.

Read Full Article

Regeneus Ltd (ASX:RGS) Quarterly Report

🕔7/31/2020 4:04:34 PM 3481

During the quarter, Regeneus Ltd (ASX:RGS) received notification from Kyocera Corporation (TYO:6971) that its lead stem cell platform technology Progenza for the treatment of Knee Osteoarthritis (Progenza OA) had passed Kyocera's due diligence process.

Read Full Article

Regeneus Ltd (ASX:RGS) Progenza OA Kyocera Negotiations Update

🕔7/28/2020 9:34:41 AM 3998

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today provides an update on its negotiations with Kyocera Corporation (TYO:6971) for a licence agreement to develop and commercialise Progenza for Knee Osteoarthritis in Japan

Read Full Article

Regeneus Ltd (ASX:RGS) Kyocera completes Progenza Due Diligence

🕔5/18/2020 8:39:52 AM 4835

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced that it has received notification that Kyocera Corporation (TYO:6971) has completed its due diligence process on its lead stem cell platform technology Progenza for treatment of Knee Osteoarthritis (Progenza OA).

Read Full Article

Regeneus Ltd (ASX:RGS) Signs MOU with Kyocera Corporation

🕔3/2/2020 10:23:45 AM 4617

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, today announced it has signed a non-binding MOU with Kyocera Corporation (Kyocera, TYO:6971).

Read Full Article

Asian Markets Overview of April 1: Tokyo Gas (TYO:9531) to Join BG Group's (LON:BG) LNG Project in Australia

🕔4/1/2010 1:30:51 PM 20647

Wall Street overnight fell on the unexpected drop of the private sector employment data, which raised investors' concern over the key nonfarm payroll figures to be released on Friday. Asian markets were mostly lower Wednesday. Japan's Nikkei index closed slightly lower with a 0.1 per cent fall on the last day of the current fiscal year for most Japanese companies. China's Shanghai Composite and Hong Kong's Hang Seng Index both lost 0.6 per cent. Today China is due to release PMI figures for the manufacturing sector.

Read Full Article

Asian Markets Overview of January 11

🕔1/11/2010 1:30:13 PM 15780

US stocks was slightly higher on Friday, hitting at least 15-month closing highs despite a bigger-than-expected job loss data. US dollar was lowered on the disappointing payroll data. This week the US firms, which are widely expected to show significant improvement compared to the corresponding period last year, will kick off the quarterly earnings reporting season.

Read Full Article

Asian Markets Overview of March 10

🕔3/10/2009 3:00:12 PM 14400

Most Asian markets declined on Monday. Japan's Nikkei average tumbled 1.2% to a 26-year low, while Hong Kong's Hang Seng Index slumped 4.8%, the sharpest fall in the major indexes in Asia. China's Shanghai Composite was down 3.4%. But South Korea's Kospi ended 1.6% higher lifted by technology and shipbuilding sectors.

Read Full Article
###

258,929 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 52) (Last 30 Days: 237) (Since Published: 34877) 

Company Data

    Headquarters
  • 6 Takeda Tobadono-cho, Fushimi-ku, Kyoto 612-8501, JAPAN
  • Telephone
  • +81-75-604-3500 
  • Fax
  • +81-75-604-3501 
  • CEOYasuo Nishiguchi  Principal Sector
  • Nanotechnology 
  • Principal Industry
  • Electronics & Equipment 
  • Employees
  • 13,937 
  • Homepage
  • global.kyocera.com/
  • E:
  • elly-yoshikawa@kyocera.co.jp